{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:18:14Z","timestamp":1793596694492,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s11605-022-05495-7","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T10:02:51Z","timestamp":1666605771000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of Peri-operative Chemotherapy in Stage II (pT2N0) Gallbladder Cancers"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-1683","authenticated-orcid":false,"given":"Aditya","family":"Kunte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-6825","authenticated-orcid":false,"given":"Shraddha","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8033-0277","authenticated-orcid":false,"given":"Vikram","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-1573","authenticated-orcid":false,"given":"Mahesh","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1007\/s11605-022-05495-7_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/cco.2019.08.03","article-title":"Epidemiology of gallbladder cancer in India","volume":"8","author":"Dutta","year":"2019","journal-title":"Chin Clin Oncol."},{"issue":"2","key":"10.1007\/s11605-022-05495-7_bb0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.soc.2008.12.004","article-title":"Surgical management of gallbladder cancer","volume":"18","author":"Reddy","year":"2009","journal-title":"Surgical Oncology Clinics of North America."},{"issue":"9","key":"10.1007\/s11605-022-05495-7_bb0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.hpb.2017.05.010","article-title":"Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis","volume":"19","author":"Ghidini","year":"2017","journal-title":"Hpb."},{"issue":"8","key":"10.1007\/s11605-022-05495-7_bb0025","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract","year":"2002","journal-title":"Cancer."},{"issue":"7","key":"10.1007\/s11605-022-05495-7_bb0030","doi-asserted-by":"crossref","first-page":"djw324","DOI":"10.1093\/jnci\/djw324","article-title":"Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival","volume":"109","author":"Mitin","year":"2017","journal-title":"JNCI Journal of the National Cancer Institute."},{"issue":"10","key":"10.1007\/s11605-022-05495-7_bb0035","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11605-015-2922-0","article-title":"Adjuvant therapy for gallbladder cancer: an analysis of the National Cancer Data Base","volume":"19","author":"Hoehn","year":"2015","journal-title":"Journal of Gastrointestinal Surgery."},{"issue":"3","key":"10.1007\/s11605-022-05495-7_bb0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/cncr.22815","article-title":"Recent trends of gallbladder cancer in Japan: an analysis of 4770 patients","volume":"110","author":"Kayahara","year":"2007","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society."},{"issue":"9","key":"10.1007\/s11605-022-05495-7_bb0045","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.hpb.2018.03.008","article-title":"Outcome of neoadjuvant chemotherapy in \u201clocally advanced\/borderline resectable\u201d gallbladder cancer: the need to define indications","volume":"20","author":"Chaudhari","year":"2018","journal-title":"HPB."},{"issue":"5","key":"10.1007\/s11605-022-05495-7_bb0050","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2016.12.058","article-title":"Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes","volume":"224","author":"Creasy","year":"2017","journal-title":"Journal of the American College of Surgeons."},{"issue":"9","key":"10.1007\/s11605-022-05495-7_bb0055","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1245\/s10434-016-5197-0","article-title":"Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm","volume":"23","author":"Engineer","year":"2016","journal-title":"Annals of surgical oncology."},{"issue":"4","key":"10.1007\/s11605-022-05495-7_bb0060","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.7314\/APJCP.2016.17.4.2137","article-title":"Radiological downstaging with neoadjuvant therapy in unresectable gall bladder cancer cases","volume":"17","author":"Agrawal","year":"2016","journal-title":"Asian Pacific Journal of Cancer Prevention."},{"issue":"3","key":"10.1007\/s11605-022-05495-7_bb0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12029-015-9742-z","article-title":"Reduced dose intensity of chemotherapy may not lead to inferior palliation in locally advanced carcinoma of the gall bladder: An experience from a regional cancer centre in Eastern India","volume":"46","author":"Gangopadhyay","year":"2015","journal-title":"Journal of gastrointestinal cancer."},{"issue":"1","key":"10.1007\/s11605-022-05495-7_bb0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13193-015-0377-0","article-title":"Resection after neoadjuvant chemotherapy in advanced carcinoma of the gallbladder: a retrospective study","volume":"6","author":"Selvakumar","year":"2015","journal-title":"Indian Journal of Surgical Oncology."},{"issue":"3","key":"10.1007\/s11605-022-05495-7_bb0075","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-015-4768-9","article-title":"Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery","volume":"22","author":"Kato","year":"2015","journal-title":"Annals of surgical oncology."},{"issue":"1","key":"10.1007\/s11605-022-05495-7_bb0080","first-page":"51","article-title":"Neoadjuvant chemoradiotherapy in gallbladder cancer","volume":"132","author":"de Aretxabala","year":"2004","journal-title":"Revista Medica de Chile."},{"issue":"11","key":"10.1007\/s11605-022-05495-7_bb0085","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s11605-019-04104-4","article-title":"Role of adjuvant chemotherapy in resected T2N0 gall bladder cancer","volume":"23","author":"Kattepur","year":"2019","journal-title":"Journal of Gastrointestinal Surgery."},{"issue":"3\u20134","key":"10.1007\/s11605-022-05495-7_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000322914","article-title":"Outcome of adjuvant therapy for gallbladder cancer","volume":"79","author":"Park","year":"2010","journal-title":"Oncology."},{"issue":"40","key":"10.1007\/s11605-022-05495-7_bb0095","doi-asserted-by":"crossref","first-page":"11481","DOI":"10.3748\/wjg.v21.i40.11481","article-title":"Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: a meta-analysis","volume":"21","author":"Annunziata","year":"2015","journal-title":"World Journal of Gastroenterology: WJG."},{"issue":"1","key":"10.1007\/s11605-022-05495-7_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","article-title":"Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma","volume":"45","author":"Petrowsky","year":"2006","journal-title":"Journal of hepatology."},{"issue":"3","key":"10.1007\/s11605-022-05495-7_bb0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cpet.2015.03.001","article-title":"FDG PET\/CT in pancreatic and hepatobiliary carcinomas: value to patient management and patient outcomes","volume":"10","author":"Parikh","year":"2015","journal-title":"PET clinics."},{"issue":"6","key":"10.1007\/s11605-022-05495-7_bb0110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/13651820802286910","article-title":"Does PET\u2013CT scan have a role prior to radical re-resection for incidental gallbladder cancer?","volume":"10","author":"Shukla","year":"2008","journal-title":"HPB."},{"issue":"6","key":"10.1007\/s11605-022-05495-7_bb0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/jso.24198","article-title":"Role of PET CT scan in redefining treatment of incidental gall bladder carcinoma","volume":"113","author":"Goel","year":"2016","journal-title":"Journal of Surgical Oncology."},{"issue":"9","key":"10.1007\/s11605-022-05495-7_bb0120","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11605-012-1935-1","article-title":"Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins","volume":"16","author":"Glazer","year":"2012","journal-title":"Journal of gastrointestinal surgery."},{"issue":"10","key":"10.1007\/s11605-022-05495-7_bb0125","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2217\/fon.14.308","article-title":"Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer","volume":"11","author":"Sirohi","year":"2015","journal-title":"Future Oncology."},{"issue":"11","key":"10.1007\/s11605-022-05495-7_bb0130","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1245\/s10434-021-09687-4","article-title":"Revision Surgery for Incidental Gallbladder Cancer\u2014Challenging the Dogma: Ideal Timing and Real-World Applicability","volume":"28","author":"Patkar","year":"2021","journal-title":"Annals of Surgical Oncology."}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-022-05495-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-022-05495-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-022-05495-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:08:59Z","timestamp":1761077339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1091255X23000975"],"URL":"https:\/\/doi.org\/10.1007\/s11605-022-05495-7","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Peri-operative Chemotherapy in Stage II (pT2N0) Gallbladder Cancers","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-022-05495-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}